KYMR
Kymera Therapeutics Inc.
$80.77
+$1.88(+2.38%)
56
Overall
55
Value
60
Tech
55
Quality
Market Cap
$6.43B
Volume
503.07K
52W Range
$28.06 - $103.00
Target Price
$118.27
EPS Estimates Overview
| Current Quarter | $-0.7 | Next Quarter | $-0.98 |
| Current Year | $-3.34 | Next Year | $-4.2 |
| QoQ Growth | -40.0% | YoY Growth | -25.7% |
| 3Y EPS CAGR | -8.7% | Target Price | $118.27 |
| Consensus | Buy | Upside | +46.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $80.77 | +2.4% | 503.07K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW